Search by Drug Name or NDC
NDC 00409-9300-10 Ropivacaine Hydrochloride 2 mg/mL Details
Ropivacaine Hydrochloride 2 mg/mL
Ropivacaine Hydrochloride is a EPIDURAL; INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ROPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-9300 |
|---|---|
| Product ID | 0409-9300_f5cd7992-66a9-410a-a486-110cd85228a2 |
| Associated GPIs | 69100070102008 |
| GCN Sequence Number | 028217 |
| GCN Sequence Number Description | ropivacaine HCl/PF VIAL 2 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 46081 |
| HICL Sequence Number | 036674 |
| HICL Sequence Number Description | ROPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | Ropivacaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ROPIVACAINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090194 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-9300-10 (00409930010)
| NDC Package Code | 0409-9300-10 |
|---|---|
| Billing NDC | 00409930010 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-9300-10) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-9300-11) |
| Marketing Start Date | 2014-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |